4/A//SEC Filing
Kay Robert 4/A
Accession 0001104659-20-118870
CIK 0001420720other
Filed
Oct 27, 8:00 PM ET
Accepted
Oct 28, 2:40 PM ET
Size
6.0 KB
Accession
0001104659-20-118870
Insider Transaction Report
Form 4/AAmended
iBio, Inc.IBIO
KAY ROBERT
DirectorExecutive Chairman and CEO
Transactions
- Award
Stock Option
2020-06-12+400,000→ 400,000 totalExercise: $1.57From: 2020-06-12Exp: 2030-06-12→ Common Stock (400,000 underlying)
Footnotes (2)
- [F1]This amendment on Form 4/A is being filed to amend the original Form 4 filed by the reporting person on June 16, 2020 (the "Original Form 4") solely to amend the exercise price in Column 2 of Table II which was incorrectly reported in the Original Form 4. All other information in the Original Form 4 remains unchanged.
- [F2]Immediate vesting as to 50,000 shares of Common Stock underlying the option and the remaining shares vest pro rata on a monthly basis over the next 21 months.
Documents
Issuer
iBio, Inc.
CIK 0001420720
Entity typeother
Related Parties
1- filerCIK 0001285612
Filing Metadata
- Form type
- 4/A
- Filed
- Oct 27, 8:00 PM ET
- Accepted
- Oct 28, 2:40 PM ET
- Size
- 6.0 KB